Directors and Advisors
The success of any company relies on the experience, energy, and talent of those spearheading the venture. It also requires a deep source of knowledge and experience from which the management team can draw. BioFactura has assembled a team of Directors and Advisors, whose range of experience includes Science, Manufacturing, Information Technology, Business, Legal, and Management. The Directors and Advisors work closely with the management team to ensure BioFactura’s growth and success.
Darryl Sampey, Director
President and Chief Executive Officer, BioFactura, Inc.
Alex Matschiner, Director
Chief Operating Officer, BioFactura, Inc.
Robert Gillette, Director
Chief Executive Officer
HealthEdge Software, Inc.
Mr. Gillette assists BioFactura with business and technology issues. Rob Gillette has over 25 years in the technology market and founded HealthEdge after nearly thirty years as an innovator in software and technology. Gillette is also the CEO of Click4Care, provider of the leading care management software platform. Gillette was the original CTO at Callidus Software (NASDAQ: CALD), the leading provider of Sales Performance Management solutions. He has also held leadership positions at Sybase, Comsat, Evolve Software and Shoppers Express, the world’s first web-based grocery shopping service. Gillette’s experience spans both large and small companies in the areas of healthcare, enterprise and financial applications, business intelligence, telecom and content management. A graduate of Vassar College, he is a primary author of Physical Database Design for Sybase SQL Server, Prentice-Hall, 1995.
Carol Lucas, Director
Carol Lucas, retired, is an early investor in BioFactura, and was one of four co-founders of Cardiocore, a leading clinical trial service firm providing FDA compliant cardiac safety management and monitoring for drug developers worldwide. During Cardiocore’s startup (2003 – 2007), Lucas served as Corporate Secretary, established and managed all non-clinical corporate functions, including contracting, HR policy development and administration, legal and investor relations, purchasing and facilities services, and liaison with outsourced partners. Following the successful negotiation and closing of Cardiocore’s first round of VC financing, Lucas retired from Cardiocore, but continues to be an active investor in the company and other ventures.
Jay Hooper, Ph.D., Advisor
Chief, Department of Molecular Virology
US Army Medical Research Institute of Infectious Diseases
Dr. Hooper serves as the Molecular Virology Branch Chief at the US Army Medical Research Institute of Infectious Diseases (USAMRIID) and the Research Coordinator for the Highly Lethal Viruses Program Area of the Military Infectious Disease Research Program (MIDRP). His research is focused on the development of medical countermeasures against Hantaviruses and Poxviruses with an emphasis on gene-based molecular vaccine technology. Dr. Hooper’s research has led to the development of a candidate gene-based molecular vaccine against smallpox and the identification of targets for immunotherapeutics. His early career included three years of military service (1986-89) gaining practical experience working with high-containment viruses at USAMRIID. After graduate school, he returned to USAMRIID in 1995 as a National Research Council associate, and then became a civilian scientist in 1998. Dr. Hooper is the first or corresponding author on more than half of his 30 peer-reviewed publications and 5 patents. He is also the author of several book chapters, mostly on Hantaviruses. Dr. Hooper received a B.A. in Biology from Colby College in 1986 and a Ph.D. in Virology from Harvard University in 1995.